Inventaire - your friends and communities are your best library

Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence

Author

Ana C. Gales

Michael B Edmond

Alexandre R. Marra

Published in: BMC Infectious Diseases

Date of publication: February 14, 2006

Language: English

Main subject: Klebsiella pneumoniae, beta-lactamase

Bibliographic databases:

Cites articles 31

Date

Title

Authors

May 1, 1965

TREATMENT OF PYELONEPHRITIS: BACTERIAL, DRUG AND HOST FACTORS IN SUCCESS OR FAILURE AMONG 252 PATIENTS
January 1, 1965

MALNUTRITION IN UNDERDEVELOPED COUNTRIES
November 1, 1983

Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens
June 1988

CDC definitions for nosocomial infections, 1988

,
September 1, 1989

Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae
September 1, 1991

More extended-spectrum beta-lactamases
December 1993

A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study
December 22, 1993

A New Simplified Acute Physiology Score (SAPS II) Based on a European/North American Multicenter Study
November 1, 1994

Bacteremia due to Acinetobacter species other than Acinetobacter baumannii,Bacteremia due toAcinetobacter species other thanAcinetobacter baumannii
August 1, 1996

Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen
September 1, 1996

Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation
August 1, 1997

Antimicrobial Susceptibility of Klebsiella pneumoniae Producing Extended-Spectrum beta-lactamase (ESBL) Isolated in Hospitals in Brazil
November 1, 1998

The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection
July 1, 1998

Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997),Bacterial Pathogens Isolated from Patients with Bloodstream Infection: Frequencies of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)

,
February 1, 1998

Epidemiology of Klebsiella bacteraemia: a case control study using Escherichia coli bacteraemia as control
July 1, 1999

Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia
July 1, 2000

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting
March 1, 2000

A one-year prospective study of nosocomial bacteraemia in ICU and non-ICU patients and its impact on patient outcome
June 1, 2001

Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory
March 21, 2001

New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy
May 1, 2001

Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region
April 1, 2001

SHV-27, a novel cefotaxime-hydrolysing beta-lactamase, identified in Klebsiella pneumoniae isolates from a Brazilian hospital
January 1, 2001

Clinical significance and impact on mortality of extended-spectrum beta lactamase-producing Enterobacteriaceae isolates in nosocomial bacteremia
March 26, 2001

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes
January 1, 2001

An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum beta-lactamase

, , ,
October 17, 2002

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome
October 1, 2002

Clinical implications of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteraemia
January 1, 2003

Risk factors in the acquisition of extended-spectrum beta-lactamase Klebsiella pneumoniae: a case-control study in a district teaching hospital in Taiwan
December 1, 2004

Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy

, , , ,
February 1, 2004

Klebsiella pneumoniae with multiple antimicrobial resistance
June 1, 2005

Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection

, , , ,

Article -

Welcome to inventaire

The library of your friends and communities

Learn more